Literature DB >> 10342864

Targeted disruption of the estrogen receptor-alpha gene in female mice: characterization of ovarian responses and phenotype in the adult.

D W Schomberg1, J F Couse, A Mukherjee, D B Lubahn, M Sar, K E Mayo, K S Korach.   

Abstract

Targeted disruption of the mouse estrogen receptor-alpha gene (estrogen receptor-alpha knockout; ERKO) results in a highly novel ovarian phenotype in the adult. The ERKO mouse model was used to characterize ER alpha-dependent processes in the ovary. Visualization of the ovaries of 10-, 20-, and 50-day-old wild-type (WT) and ERKO mice showed that the ERKO phenotype developed between 20 and 50 days of age. Developmental progression through the primordial, primary, and antral follicle stages appeared normal, but functional maturation of preovulatory follicles was arrested resulting in atresia or in anovulatory follicles, which in many cases formed large, hemorrhagic cysts. Corpora lutea were absent, which also indicates that the normal biochemical and mechanical processes that accomplish ovulation were compromised. Northern and ribonuclease protection analyses indicated that ERKO ovary FSH receptor (FSHR) messenger RNA (mRNA) expression was approximately 4-fold greater than in WT controls. Ovarian LH receptor (LHR) mRNA expression was also higher in the ERKO animals. Cellular localization studies by in situ hybridization analysis of ERKO ovaries showed a high level of LHR mRNA expression in the granulosa and thecal layers of virtually all the antral follicles. Ribonuclease protection analyses showed that ovarian progesterone receptor and androgen receptor mRNA expression were similar in the two groups. These results indicated that ER alpha action was not a prerequisite for LHR mRNA expression by thecal or granulosa cells or for ovarian expression of progesterone receptor mRNA. Ovarian estrogen receptor beta (ER beta) was detected immunohistochemically, was sharply compartmentalized to the granulosa cells, and was expressed approximately equally in the ERKO animals and the WT controls. In contrast, ER alpha staining was present in the thecal cells but not the granulosa cells of the WT animals. The summary findings indicate that in the adult the major cause of the ERKO phenotype is high circulating LH interacting with functional LHR of the theca and granulosa cells. These features result in a failure of the normal maturational events leading to successful ovulation and luteinization and presumably involve both hypothalamic-pituitary and intraovarian mechanisms dependent upon ER alpha action. The presence of ER beta in the granulosa cells did not rescue the phenotype of the ovary.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10342864     DOI: 10.1210/endo.140.6.6823

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  49 in total

1.  Transactivation of microRNA-383 by steroidogenic factor-1 promotes estradiol release from mouse ovarian granulosa cells by targeting RBMS1.

Authors:  Mianmian Yin; Mingrong Lü; Guidong Yao; Hui Tian; Jie Lian; Lin Liu; Meng Liang; Yong Wang; Fei Sun
Journal:  Mol Endocrinol       Date:  2012-05-16

2.  Female mice expressing constitutively active mutants of FSH receptor present with a phenotype of premature follicle depletion and estrogen excess.

Authors:  Hellevi Peltoketo; Leena Strauss; Riikka Karjalainen; Meilin Zhang; Gordon W Stamp; Deborah L Segaloff; Matti Poutanen; Ilpo T Huhtaniemi
Journal:  Endocrinology       Date:  2010-02-19       Impact factor: 4.736

Review 3.  Estrogen receptor beta, a possible tumor suppressor involved in ovarian carcinogenesis.

Authors:  Gwendal Lazennec
Journal:  Cancer Lett       Date:  2006-01-18       Impact factor: 8.679

4.  The intraovarian actions of estrogen receptor-alpha are necessary to repress the formation of morphological and functional Leydig-like cells in the female gonad.

Authors:  John F Couse; Mariana M Yates; Karina F Rodriguez; Jo Anne Johnson; Donald Poirier; Kenneth S Korach
Journal:  Endocrinology       Date:  2006-04-20       Impact factor: 4.736

Review 5.  Hyperandrogenic origins of polycystic ovary syndrome - implications for pathophysiology and therapy.

Authors:  David H Abbott; Daniel A Dumesic; Jon E Levine
Journal:  Expert Rev Endocrinol Metab       Date:  2019-02-15

6.  17β-estradiol inhibits spreading of metastatic cells from granulosa cell tumors through a non-genomic mechanism involving GPER1.

Authors:  Charlotte M François; Richard Wargnier; Florence Petit; Thibaut Goulvent; Ruth Rimokh; Isabelle Treilleux; Isabelle Ray-Coquard; Valeria Zazzu; Joëlle Cohen-Tannoudji; Céline J Guigon
Journal:  Carcinogenesis       Date:  2015-03-30       Impact factor: 4.944

7.  Generation and characterization of a complete null estrogen receptor alpha mouse using Cre/LoxP technology.

Authors:  Ming Chen; Andrew Wolfe; Xi Wang; Chawnshang Chang; Shuyuan Yeh; Sally Radovick
Journal:  Mol Cell Biochem       Date:  2008-10-25       Impact factor: 3.396

Review 8.  Estrogen and neurodegeneration.

Authors:  Sam Gandy
Journal:  Neurochem Res       Date:  2003-07       Impact factor: 3.996

9.  Hormonal coordination of natriuretic peptide type C and natriuretic peptide receptor 3 expression in mouse granulosa cells.

Authors:  Kyung-Bon Lee; Meijia Zhang; Koji Sugiura; Karen Wigglesworth; Tracy Uliasz; Laurinda A Jaffe; John J Eppig
Journal:  Biol Reprod       Date:  2013-02-21       Impact factor: 4.285

10.  Generation of Cyp17iCre transgenic mice and their application to conditionally delete estrogen receptor alpha (Esr1) from the ovary and testis.

Authors:  Phillip J Bridges; Yongbum Koo; Dong-Wook Kang; Susan Hudgins-Spivey; Zi-Jian Lan; Xueping Xu; Francesco DeMayo; Austin Cooney; CheMyong Ko
Journal:  Genesis       Date:  2008-09       Impact factor: 2.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.